LSALT Peptide

DB16472InvestigationalProtein Based Therapies

LSALT Peptide: Overview.

Mechanism: LSALT peptide is an anti-inflammatory drug that inhibits dipeptidase-1 (DPEP1), a novel adhesion receptor.
Curator reviewed
Also known as: H-LSALTPSPSWLKYKAL-NH2 · LSALT · Metablok

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with LSALT Peptide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.